Comment on ‘Testing patterns, patient and tumour characteristics and survival by NRAS and KIT genotype in melanoma’: can survival associations be inferred from selectively tested populations?

Clicks: 39
ID: 316900
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #41 of 252 articles by views in clinical and experimental dermatology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 252 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In this correspondence, we comment on the recent study by Mistry et al. examining *NRAS* and *KIT* testing patterns and survival in melanoma using a national English cohort. While acknowledging the important contribution of this large real-world dataset, we raise considerations regarding the interpretation of genotype–survival associations derived from selectively tested populations, where clinically driven molecular testing may introduce selection-related biases. We suggest that caution may be warranted when interpreting the apparent lack of prognostic association between *NRAS* mutation status and survival and emphasize the need for more systematically genotyped cohorts to clarify biological prognostic effects.
Reference Key
openalex_W7164149117 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal clinical and experimental dermatology
Year 2026
DOI
10.1093/ced/llag246
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.